Absolute bioavailability and dose proportionality of BMS-181885, an antimigraine agent, following the administration of single intranasal doses to cynomolgus monkeys
- J Pharm Sci. 1998 Sep;87(9):1170-2. doi: 10.1021/js9802042.
Affiliations
- 1. Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Route 206 and Provinceline Road, Princeton, New Jersey 08543-4000, USA.
PMID: 9724572
DOI: 10.1021/js9802042
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: 5-HT ReceptorResearch Areas: Neurological Disease